Aspen Neuroscience Stock (NASDAQ:ASPE)
Previous Close
$12.29
52W Range
$11.20 - $14.90
50D Avg
$13.41
200D Avg
$13.41
Market Cap
$371.04M
Avg Vol (3M)
$852.90K
Beta
-
Div Yield
-
ASPE Company Profile
Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company, which engages in the development of autologous induced pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases. Its product candidate, sasineprocel, is an investigational single-dose, autologous iPSC-based cell therapy for the treatment of Parkinson's disease (PD). The company was founded by Jeanne F. Loring and Andrés Bratt-Leal in 2018 and is headquartered in San Diego, CA.